SYGNIS PHARMA

sygnis-pharma-logo

SYGNIS Pharma AG, a specialty pharmaceutical company, engages in the research, development, and marketing of drugs for the treatment of disorders of the central nervous system (CNS). These include stroke or various forms of dementia. AX200 AX200 is a biological molecule, developed by the company for the treatment of neurodegenerative diseases. It is being tested in a 350 patient, multinational phase II efficacy trial. AX200 is an endogenous protein. As part of the body's own protective action th... e production of AX200 is boosted after brain damage. AX200 displays a multimodal activity: it stops neuronal cell death in the acute phase of the disease while at the same time stimulating the regeneration of the damaged CNS through the stimulation of neurogenesis, as well as arteriogenesis and the reorganisation of neuronal networks. Significant Events The company acquired Amnestix Inc. in 2008. Its business operations focus on the development of novel therapeutics and diagnosis techniques to enhance cognitive and memory functions. History SYGNIS Pharma AG was founded in 1997.

#SimilarOrganizations #People #Financial #Website #More

SYGNIS PHARMA

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1997-01-01

Address:
Heidelberg, Baden-Wurttemberg, Germany

Country:
Germany

Website Url:
http://www.sygnis.de

Total Employee:
1+

Status:
Active

Contact:
+49062213540120

Email Addresses:
[email protected]

Technology used in webpage:
Domain Not Resolving


Similar Organizations

cardiokine-logo

Cardiokine

Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of

gentium-logo

Gentium

Gentium S.p.A. is public (GENT - NASDAQ) biopharmaceutical company specializing in the discovery, research, development and manufacture of

metp-pharma-logo

MetP Pharma

MetP Pharma is a privately held company, focusing on the nasal delivery of drugs to the systemic circulation and brain.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.

viropharma-logo

ViroPharma

ViroPharma, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases

Current Employees Featured

dietmar-hopp_image

Dietmar Hopp
Dietmar Hopp Co-Founder @ Sygnis Pharma
Co-Founder

heikki-lanckriet_image

Heikki Lanckriet
Heikki Lanckriet CEO @ Sygnis Pharma
CEO
2016-08-01

Founder


dietmar-hopp_image

Dietmar Hopp

Stock Details


Company's stock symbol is ETR:LIO1

Acquisitions List

Date Company Article Price
2018-05-08 TGR BioSciences TGR BioSciences acquired by Sygnis Pharma N/A
2017-06-26 Expedeon Expedeon acquired by Sygnis Pharma 11.5 M EUR
2017-06-26 Innova Biosciences Innova Biosciences acquired by Sygnis Pharma 11.5 M EUR
2016-12-21 C.B.S. Scientific Company C.B.S. Scientific Company acquired by Sygnis Pharma 900 K USD
2008-06-08 Amnestix Amnestix acquired by Sygnis Pharma 6.3 M USD

Official Site Inspections

http://www.sygnis.de

Unable to get host informations!!!

Loading ...

More informations about "Sygnis Pharma"

SYGNIS AG: SYGNIS AG gibt vollständige Integration der kürzlich ...

Apr 11, 2017 Pilar de la Huerta Co-CEO/CBDO Tel.: +34 91 192 36 50 E-Mail: [email protected]. MC Services AG Raimund Gabriel Managing Partner Tel.: +49 89 โ€ฆSee details»

Ygnis - Expert in heating solutions for commercial applications

Die Firma YGNIS AG in Ruswil ist ein sich stetig weiter entwickelnder, international führender Anbieter von Produkten für die Wärmeerzeugung und gehört der französischen Groupe โ€ฆSee details»

Home | ACV Ygnis

Recientemente las soluciones colectivas en agua caliente sanitaria de ACV han entrado a formar parte del catálogo de YGNIS, consolidando así uno de los mayores porfolios en soluciones de โ€ฆSee details»

SYGNIS AG Profile | The Scientist

SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today announced it โ€ฆSee details»

SYGNIS passt Organisation an neue Geschäftstätigkeit an

SYGNIS Pharma AG gab die Einstellung seines therapeutischen Entwicklungsprojektes KIBRA und eine Anpassung der Organisation an die neue Geschäftstätigkeit der Gesellschaft โ€ฆSee details»

Legal Information - Ygnis Germany

This website is published by Ygnis AG. A Limited Company. Share capital : 2 900 000 CHF. Registered office : 31-33, Wolhuserstrasse -6017 Ruswil (Switzerland) Registration number: โ€ฆSee details»

Home - Ygnis Italia

Ygnis è stato creato più di 80 anni fa. Scopri di più sulla nostra storia. Ulteriori informazioni. Chiedi per un preventivo. Se vuoi sviluppare il tuo progetto con i nostri prodotti, puoi chiedere un โ€ฆSee details»

SYGNIS | LinkedIn

SYGNIS | 572 Follower:innen auf LinkedIn. SYGNIS is a German stocklisted company devoted to the development of novel, superior tools for molecular biology that play key roles in changing โ€ฆSee details»

WELCOME TO YGNIS AG SWITZERLAND, GERMANY, AUSTRIA

YGNIS AG SWITZERLAND Wolhuserstrasse 1-33 6017, Ruswil, Switzerland Tel. +41 (0) 41 496 91 20 Fax +41 (0) 41 496 91 21 [email protected] www.ygnis.comSee details»

SYGNIS AG - Lab Manager

May 13, 2018 Organization profile for SYGNIS AG on Lab Manager. Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.See details»

Firmenverzeichnis - SYGNIS Pharma AG - heidelberg.de

E-Mail [email protected]. Telefon 06221 454-6. Fax 06221 454-700. Beschreibung. Die SYGNIS Pharma AG ist ein im Prime Standard der Deutschen Börse gelistetes spezialisiertes Pharma โ€ฆSee details»

Sygnis Pharma AG โ€“ Rhein-Neckar-Wiki

Die Sygnis Pharma AG ist ein Biotechnologieunternehmen mit Sitz in Heidelberg, das sich auf die Enwicklung und Vermarktung neuartiger molekularbiologischer Technologien konzentriert.. โ€ฆSee details»

SYGNIS SA : Aktionäre Vorstände Geschäftsführer und โ€ฆ

SYGNIS SA : Vorstellung des Unternehmens SYGNIS SA, Aktionäre, Vorstände und Berufsbeschreibung, Finanzstärkerating, offizielle Mitteilungen, Kontaktdaten und โ€ฆSee details»

Home - Ygnis Suisse

Die Firma YGNIS AG in Ruswil ist ein sich stetig weiter entwickelnder, international führender Anbieter von Produkten für die Wärmeerzeugung und gehört der französischen Groupe โ€ฆSee details»

Sygnis AG: Science and business rolled into one - European ...

Jul 4, 2017 German-Spanish biotech Sygnis AG has made changes to its management team and supervisory board. Heikki Lanckriet, who was previously Co-CEO, will become sole CEO โ€ฆSee details»

Sygnis Pharma AG - Rhein-Neckar-Wiki

Nov 29, 2006 Die Sygnis Pharma AG ist ein Biotechnologieunternehmen mit Sitz in Heidelberg, das sich auf die Enwicklung und Vermarktung neuartiger molekularbiologischer Technologien โ€ฆSee details»

SYGNIS Bioscience GmbH & Co. KG, Heidelberg - North Data

SYGNIS Bioscience GmbH & Co. KG, Heidelberg, Amtsgericht Frankfurt am Main HRA 42769: Netzwerk, WirtschaftsinfosSee details»

Ygnis - Expert in heating solutions for commercial applications

Born in Switzerland in 1943, Ygnis joined Groupe Atlantic in 2003 and became an international brand. Ygnis is specialised in condensing gas boilers, pressurised boilers, hot water storage, โ€ฆSee details»

Sygnis bekommt zwei neue Vorstandsmitglieder - 3Druck.com

Am 9. Januar 2023 ernannte der Aufsichtsrat von Sygnis Olga Czerwiล„ska und Joanna Danaj zu Vorstandsmitgliedern. Im Gegenzug trat der derzeitigeSee details»

Brennwert-Kompaktwärmezentralefür Gas 40 - 100 kW

YGNIS AG Heizkessel und Wassererwärmer Wolhuserstrasse 31/33 6017 Ruswil CH Telefon +41 (0) 41 496 91 20 Telefax +41 (0) 41 496 91 21 E-mail: [email protected] www.ygnis.ch โ€ฆSee details»

linkstock.net © 2022. All rights reserved